Beclate 100 hfa Inhaler

Beclate 100 Hfa Inhaler (Beclometasone, commonly as beclometasone dipropionate) is a potent synthetic glucocorticoid with strong anti‑inflammatory, anti‑allergic, and antipruritic properties. It is prescribed for the long‑term management of chronic inflammatory conditions affecting the airways, nasal passages, gastrointestinal tract, and skin. By targeting local inflammation and breaking down rapidly in the liver, Beclate 100 Hfa Inhaler helps reduce swelling, mucus production, and allergic responses while limiting systemic side effects. It is available in multiple formulations (including inhalers, nasal sprays, oral tablets, capsules, and topical creams or ointments), allowing tailored delivery to the site of disease.

Beclate 100 Hfa Inhaler is a corticosteroid medicine in the glucocorticoid class. It is used to help reduce inflammation and allergic reactions in different parts of the body, depending on the formulation.

After administration, beclometasone is converted into its active form, beclometasone-17-monopropionate (17-BMP). This active form binds to glucocorticoid receptors inside cells and influences the way certain genes are expressed. As a result, the production of inflammatory substances such as prostaglandins and leukotrienes is reduced, which helps lower swelling, redness, and irritation.

In the lungs, Beclate 100 Hfa Inhaler helps reduce airway inflammation and mucus production. This may improve breathing and help reduce the risk of asthma or Chronic Obstructive Pulmonary Disease (COPD) flare-ups. In the nose, it is used to help relieve symptoms such as congestion, sneezing, and irritation associated with allergic rhinitis or nasal polyps. In some oral formulations, it acts locally in the gut to reduce inflammation in conditions such as ulcerative colitis, helping ease symptoms like abdominal pain and diarrhoea. Topical forms are applied to the skin to help manage inflammatory conditions such as eczema, psoriasis, and dermatitis.

Beclometasone is designed to act mainly at the site of inflammation, so only small amounts usually enter the bloodstream when used as directed. This reduces the risk of systemic effects compared with oral corticosteroids such as prednisolone. However, with prolonged use or higher exposure than recommended, systemic effects such as adrenal suppression, reduced bone density, or eye-related changes may still occur.

This medicine should be used under medical supervision. The dose, formulation, and duration depend on the condition being treated. It is not intended for immediate relief of sudden symptoms, as its effects develop gradually with regular use. If it has been used for a long period, it should not be stopped suddenly without medical advice, as gradual dose reduction may sometimes be required.

Beclate 100 Hfa Inhaler may be indicated by your doctor for:

Asthma

Long-term prevention and control of asthma symptoms and attacks; available as metered-dose inhalers and dry powder inhalers for both adults and children.

Chronic Obstructive Pulmonary Disease (COPD)

To reduce airway inflammation, exacerbations, and symptoms, often used in combination with long-acting bronchodilators.

Allergic Rhinitis

Nasal spray formulation to reduce nasal congestion, sneezing, itching, and nasal discharge caused by seasonal or perennial allergies.

Rhinosinusitis

To manage inflammation in the nasal passages and sinuses; helps alleviate congestion and drainage symptoms.

Nasal Polyps

To reduce the size and symptoms of nasal polyps in patients with chronic rhinosinusitis.

Dermatitis and Eczema

Topical creams and ointments for localised management of atopic dermatitis, contact dermatitis, seborrheic dermatitis, and other inflammatory skin conditions.

Pruritus

As an antipruritic agent to reduce itching associated with various inflammatory skin conditions.

Beclate 100 Hfa Inhaler may provide benefits such as:

• Target the site of inflammation with topical delivery, causing significantly fewer systemic side effects compared to oral prednisolone or dexamethasone.

• Progressively lower inflammation in the airways and nasal passages, thus decreasing the frequency and severity of asthma attacks and reducing exacerbations.

• Reduce the need for rescue inhalers (short-acting bronchodilators) through preventive action and maintenance of baseline airway function.

• Improve nasal breathing, reduce congestion, and alleviate allergy-related nasal symptoms when used as a nasal spray.

• Relieve skin inflammation, itching, and erythema when applied topically to affected skin areas.

• Be used for long-term maintenance therapy in appropriate formulations after consulting with a licensed medical physician.

• Be administered via multiple routes (inhaled, nasal, oral, or topical), allowing targeted delivery directly to the site of disease.

• Break down rapidly in the liver after local absorption, reducing systemic exposure and potential for systemic adverse effects

Beclate 100 Hfa Inhaler may cause side effects in some people, although many tolerate it well when used as prescribed. The type and likelihood of side effects can vary depending on the formulation (such as inhaled, nasal, topical, or oral) and duration of use.

Common side effects of Beclate 100 Hfa Inhaler may include

• Throat irritation or dryness, especially with inhaled forms

• Hoarseness or voice changes

• Oral fungal infection (thrush), particularly if the mouth is not rinsed after use

• Nasal dryness, irritation, or mild burning sensation with nasal sprays

• Cough or mild throat discomfort after inhalation

Uncommon side effects of Beclate 100 Hfa Inhaler may include

• Headache

• Nausea or mild stomach discomfort (more often with oral formulations)

• Skin thinning or easy bruising with topical use

• Sleep disturbance or restlessness in some individuals

Serious side effects that may require immediate medical attention include

• Signs of adrenal suppression, such as unusual tiredness, weakness, or dizziness

• Breathing difficulty or worsening symptoms shortly after inhalation (rare paradoxical bronchospasm)

• Eye-related changes, such as blurred vision or increased eye pressure, with long-term use

• Persistent or recurrent infections

• Features of long-term steroid exposure, such as weight gain, facial rounding, or skin changes

• Always consult your doctor if you notice any unusual symptoms while taking Beclate 100 Hfa Inhaler.

You must use Beclate 100 Hfa Inhaler exactly as prescribed by your doctor. Do not change the dose or frequency without medical advice.

• Metered-Dose Inhaler (MDI): Shake well before each use. Exhale completely to empty your lungs. Place your lips around the mouthpiece, creating a seal. Press the canister once while inhaling deeply and slowly. Hold your breath for 10 seconds. Always rinse your mouth with water and spit after each use to prevent oral candidiasis and voice hoarseness. Wait at least one minute between doses if more than one dose is prescribed.

• Nasal Spray: Gently blow your nose to clear your nasal passages. Tilt your head slightly forward. Insert the spray tip into one nostril, keeping it away from the nasal septum. Spray once while inhaling gently through the nose. Use alternate nostrils as directed. Do not tilt your head back after spraying.

• Oral Tablets/Capsules (if prescribed): Swallow whole with water. Do not crush, chew, or break. Take at the same time each day, usually in the morning before breakfast. Take with or without food, as directed by your doctor.

• Topical Cream/Ointment (if prescribed): Clean and dry the affected skin area. Apply a thin layer to the affected area. Rub gently until absorbed. Wash hands after application unless treating hands. Do not apply to the face, groin, or other sensitive areas without medical advice. Do not use for prolonged periods without medical supervision.

Beclometasone is a corticosteroid that works by reducing inflammation in the airways, nose, or skin, depending on the formulation used.

After administration, beclometasone is converted in the body into its active form, which binds to glucocorticoid receptors inside cells. This activates a series of changes in gene expression that help reduce the production of inflammatory substances such as cytokines and chemokines. As a result, swelling, redness, mucus production, and irritation in the affected tissues are gradually reduced.

It also helps suppress the activity of immune cells involved in allergic and inflammatory responses, including eosinophils and mast cells. This contributes to better long-term control of symptoms in conditions such as asthma and allergic rhinitis.

Overall, beclometasone helps manage inflammation at its source. It is not a quick-relief medicine, but with regular use it supports sustained improvement in symptoms and helps prevent flare-ups.

• Always rinse your mouth and gargle with water after using a beclometasone inhaler. This reduces the risk of oral candidiasis (thrush) and voice hoarseness.

• Beclometasone is a preventer medication, not a reliever. It will not stop a sudden asthma attack. Always carry your rescue inhaler (such as salbutamol) separately and keep it readily accessible.

• If you are switching from systemic corticosteroids to beclometasone, do not stop your previous steroid abruptly. Follow your doctor's tapering plan carefully to avoid adrenal insufficiency.

• Avoid grapefruit juice throughout your treatment, as it can substantially increase beclometasone levels in the blood and raise the risk of systemic side effects.

• If you have diabetes, monitor your blood glucose more frequently after starting beclometasone, as corticosteroids may elevate glucose levels.

• Regular monitoring of height is recommended for children receiving long-term inhaled beclometasone, as high doses may slow down the growth rate.

Store Beclate 100 Hfa Inhaler at room temperature in a dry place away from direct sunlight and heat.

• Do not freeze nasal spray solutions or nebuliser solutions.

• Keep inhalers away from open flames and extreme temperatures.

• Store oral tablets and capsules in their original packaging to protect from moisture and light.

• Store topical creams and ointments in their original containers with caps tightly closed.

• Keep all formulations out of the reach of children and pets.

• Do not use after the expiry date printed on the packaging.

• Grapefruit and Grapefruit Juice (SEVERE): Grapefruit strongly inhibits CYP3A4 enzymes that metabolise beclometasone in the gut wall and liver. This can significantly increase blood levels, especially with oral formulations, raising the risk of systemic steroid side effects like adrenal suppression and hypertension. Avoid grapefruit throughout your treatment.

• Alcohol (CAUTION): Alcohol may worsen dizziness and increase susceptibility to side effects. It may also impair immune function, particularly with high-dose long-term corticosteroid use.

• Other Citrus Fruits (CAUTION): Pomelo, Seville oranges, and tangelos may have similar effects to grapefruit due to their CYP3A4 inhibitory properties.

• Calcium and Vitamin D-Rich Foods (BENEFICIAL): Patients on long-term therapy should ensure adequate intake through diet or supplementation, as corticosteroids may reduce bone mineral density.

• CYP3A4 Inhibitors (SEVERE): Drugs such as ketoconazole, itraconazole, ritonavir, and clarithromycin strongly inhibit metabolism, leading to elevated blood levels and risk of systemic steroid toxicity.

• CYP3A4 Inducers (CAUTION): Agents like rifampicin, phenytoin, and carbamazepine accelerate metabolism, potentially reducing therapeutic effectiveness.

• Antidiabetics (CAUTION): Medicines such as insulin and metformin may interact with Beclate 100 Hfa Inhaler as it can raise blood glucose levels, complicating glycemic control.

• Live Vaccines (CAUTION): High-dose or prolonged therapy may impair immune response to live attenuated vaccines (e.g., MMR, varicella), reducing vaccine efficacy.

• Systemic Corticosteroids (CAUTION): Concurrent use increases overall steroid burden, raising the risk of adrenal suppression and Cushingoid features.

• Diabetes Mellitus (CAUTION): Beclometasone can raise blood glucose levels. Patients with diabetes should monitor glucose levels more frequently when starting or adjusting doses.

• Active Infections (SEVERE): Beclate 100 Hfa Inhaler suppresses local and systemic immune responses and may worsen latent or active tuberculosis, systemic fungal infections, or serious viral infections.

• Osteoporosis (CAUTION): Prolonged corticosteroid use, even inhaled, can reduce bone mineral density. Periodic bone density assessment (DEXA scan) may be beneficial.

• Liver Disease (CONSULT YOUR DOCTOR): Impaired hepatic metabolism reduces clearance, increasing systemic exposure. Medical consultation and possible dose adjustment are advised.

• Eye Conditions (CAUTION): Long-term use may raise intraocular pressure and worsen glaucoma or contribute to cataract formation. Regular ophthalmologic monitoring is recommended.

If you suspect an overdose, stop using the medicine and contact your doctor immediately or go to the nearest emergency department.

f you miss a dose, take or use it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Never double the dose to compensate.